NKTR
NASDAQ · Pharmaceuticals
Nektar Therapeutics
$70.67
-0.78 (-1.09%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
-40.2% upside
Low Target
$31.85
Average Target
$42.23
High Target
$63.47
Current Price
$70.67
Current
$70.67
$70.67
Target
$42.23
$42.23
$31.85
$42.23 avg
$63.47
Scenario Analysis
Bear Case
$31.85
-54.9%
Low target
Base Case
$42.23
-40.2%
Avg target
Bull Case
$63.47
+-10.2%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$109.00
-35.2% from high
52-Week Low
$21.60
+227.2% from low
Target vs 52W High
$42.23
-61.3% vs high
Next Earnings Report
Aug 13, 2026 · After Market Close
4d
until earnings
EPS Est: $-2.02
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals